Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ariella who wrote (1226)	9/11/1998 7:51:00 AM
From: Gabe Fernandez	Read Replies (2) of 1491

great thread Ariella i will save it for people with this problem. your comment at the end that maybe HU-211 will help prevent or improve this syndrome is very possible since we know that the mechanism of action decreases the area of brain damage as the ex of the army study on nerve gas research. By the way i plan to attend the New Orleans meeting. Have not decided about the Congreess of Neurological Surgeons meeting in Seattle. Waiting for the Sept 16 report that i hear about. Could u tell me the where whats of the meeting and can any stockholder attend. thanks Gabe Fernandez M.D. If u have any other interesting datas my email is gfdz1@aol.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next